611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Market cap: $788.1M (12/21/2025)
Price: $44.16
Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
Reports Third Quarter 2025 Financial Results and Provides Business Update
Reports Second Quarter 2025 Financial Results and Provides Business Update
Material disclosure
Reports First Quarter 2025 Financial Results and Provides Business Update
Annual Report to Security Holders
Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation
Changes in Board, Management or Compensation
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership